Biberach

The biopharmaceutical production facility.

The Biberach site, in the very south of Germany, is home to the largest research and development center within Boehringer Ingelheim’s global network. At this site, all research and development steps for active chemical substances as well as for biopharmaceuticals are processed. On top of that, Biberach is also one of the largest sites in Europe for the production of biopharmaceutical active substances on the basis of cell cultures. More than 7,600 employees work on the company grounds, which encompass more than 415,000 square meters.

Purification of recombinant protein solution in downstream development.

In 1946, Boehringer Ingelheim founded the Dr. Karl Thomae GmbH in Biberach. After several decades of collaboration, the German pharmaceutical business, with its locations in Ingelheim and Biberach, was restructured under one country management in 1993. Following this organizational change, both sites have focused on their designated areas within the pharmaceutical value chain: While Biberach conducts research and development, Ingelheim is responsible for production and launches. One exception is the biopharmaceutical production, which is also located in Biberach.

Employees working in a laboratory.

Throughout the years, this site has seen continuous investments. One of the largest investments ever made by Boehringer Ingelheim was realized here: the Biologicals Development Center (BDC). This latest addition to the vast company grounds includes highly modern laboratories, technologies, a production facility, and smart working areas. Since its inauguration, more than 500 employees advance the development of innovative biopharmaceutical active ingredients there.

Ridgefield

Ridgefield is home to the company’s US headquarters. The site serves as a key research center for human pharmaceuticals.

Vienna

Vienna, Austria, is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.

Ingelheim

The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. It is the largest site, serving both launch and commercial supply.

References